Medicines & Focus
Innovation Focused
on Complex Diseases
Therapeutic Areas of Focus
We are inspired by the courage and determination of individuals living with complicated and often difficult-to-treat diseases. We have a portfolio of proprietary commercial products focused on alcohol dependence, opioid dependence, schizophrenia and bipolar I disorder, and a pipeline of product candidates in development for neurological disorders and cancer.
Disease Areas
Addiction
We have been at the forefront of addiction medicine for more than a decade, seeking to help people living with alcohol dependence and opioid dependence.
Serious Mental Illness
We are committed to addressing unmet needs in serious mental illness through the development of therapeutic options to support adults living with schizophrenia and bipolar I disorder.
Cancer
We are actively researching new immuno-oncology agents for cancer patients in tumor types where we see significant need and opportunity for new treatment options.
We Develop Innovative Medicines
Alkermes’ technologies and discoveries have contributed to the development of medicines that have helped shape the treatment landscape, and form the basis for our current investigational products in a range of disease areas.
Proprietary U.S. Medicines
Our mission to make innovative medicines that may help address unmet patient needs underlies our work. Our portfolio of proprietary commercial products focuses on chronic, highly prevalent conditions that represent some of the most challenging health issues of our time.
Product Candidates in Development
Our research and development efforts are focused on the pursuit of potential new medicines that build on our heritage in neuroscience and, as scientific opportunities present themselves, advancement of our research into important new areas such as immuno-oncology.
